deoxyglucose has been researched along with Minimal Disease, Residual in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (93.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AY; El-Diery, MW; Fei, B; Griffith, CC; Little, JV; Lu, G; Patel, MR; Wang, X; Zhang, H | 1 |
| Austin, JR; Kim, EE; Wong, FC | 1 |
| Dimitrakopoulou-Strauss, A; Goldschmidt, H; Lorenz, WJ; Maier-Borst, W; Strauss, LG; van Kaick, G | 1 |
| Bassa, P; Endo, K; Inoue, T; Kim, EE; Komaki, R; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Anscher, MS; Hebert, ME; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
| Bassa, P; Buzdar, AU; Hicks, KW; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Garcia, R; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Iwata, R; Kubota, K; Reinhardt, MJ; Yaegashi, H; Yamada, S | 1 |
| Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hegenbart, U; Irngartinger, G; Oberdorfer, F; Strauss, LG; van Kaick, G | 1 |
| Beyer, W; Bumann, D; Clausen, M; de Wit, M; Herbst, K; Hossfeld, DK | 1 |
| Baddeley, H; Beaney, R; Chevretton, EB; Davis, J; Hussain, K; Maisey, M; McGurk, M; Tierney, P; Wong, WL | 1 |
| Elomaa, I; Joensuu, H; Leskinen, S; Minn, H; Nuutinen, JM; Salminen, E; Söderström, KO; Solin, O; Varpula, M | 1 |
| Eary, JF; Gold, P; Guinee, DG; Mankoff, DA; Samlowski, WE; Thompson, JA | 1 |
| Carreras Delgado, JL; Montz Andrée, R; Nieto Magro, C; Pérez Castejón, MJ | 1 |
1 review(s) available for deoxyglucose and Minimal Disease, Residual
| Article | Year |
|---|---|
[Positron emission tomography (PET) in the diagnosis and evaluation of lymphomas].
Topics: Adult; Deoxyglucose; Fluorine Radioisotopes; Humans; Lymphoma; Male; Middle Aged; Neoplasm, Residual; Prognosis; Radioimmunotherapy; Tomography, Emission-Computed | 1997 |
2 trial(s) available for deoxyglucose and Minimal Disease, Residual
| Article | Year |
|---|---|
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.
Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Whole-Body Counting | 1997 |
Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET.
Topics: Adult; Deoxyglucose; Diagnostic Errors; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
12 other study(ies) available for deoxyglucose and Minimal Disease, Residual
| Article | Year |
|---|---|
Label-free reflectance hyperspectral imaging for tumor margin assessment: a pilot study on surgical specimens of cancer patients.
Topics: 4-Chloro-7-nitrobenzofurazan; Deoxyglucose; Head and Neck Neoplasms; Humans; Machine Learning; Neoplasm, Residual; Optical Imaging; Pilot Projects; Sensitivity and Specificity | 2017 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxyglucose; Edema; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Oxygen Radioisotopes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Water | 1995 |
Detecting recurrent or residual lung cancer with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
Topics: Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Cicatrix; Deoxyglucose; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Diseases; Lung Neoplasms; Neoplasm, Residual; Prospective Studies; Remission Induction; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm, Residual; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Topics: Adult; Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Sarcoma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Deoxyglucose; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Methionine; Neoplasm, Residual; Neoplasms, Experimental; Radiopharmaceuticals; Rats; Thymidine; Tomography, Emission-Computed; Tritium | 1997 |
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Combined Modality Therapy; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome | 1997 |
A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
Topics: Carcinoma, Renal Cell; Deoxyglucose; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Interleukin-2; Kidney Neoplasms; Middle Aged; Neoplasm, Residual; Pelvic Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |